yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49887919-6F5449CE-5282-4689-816A-FB3F388A5D17
Q49887919-6F5449CE-5282-4689-816A-FB3F388A5D17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49887919-6F5449CE-5282-4689-816A-FB3F388A5D17
Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.
P2860
Q49887919-6F5449CE-5282-4689-816A-FB3F388A5D17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49887919-6F5449CE-5282-4689-816A-FB3F388A5D17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
98f46890cbb0005a41e7722bce2e8b23f5d2b743
P2860
Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer